PD-L1, as an important immune checkpoint molecule and involved in weakening the immune response to infection, can allow cancer cells to escape immune surveillance32 and has been shown in ovarian cancer, melanoma, colon adenocarcinoma, lung squamous cell carcinoma, breast adenocarcinoma, and many other cancers33. Here, CD274 is linked to breast adenocarcinoma.